Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE3

Conditions

Moderate to Severe Atopic Dermatitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Chinese Academy of Medical Sciences Hospital for Skin Diseases, Nanjing, Jiangsu, China
Contact: Study coordinator (Jin Nie)
Contact: Principal Investigator (qianjin Lu)

Study leads

qianjin Lu
Principal Investigator
Chinese Academy of Medical Sciences Hospital of Skin Disease

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis

Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE2

Oceanside, United States · Santa Monica, United States

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE2

Fountain Valley, United States · Fremont, United States

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis · Atopic · Dermatitis

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Birmingham, United States

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Peoria, United States